Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.
Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004 Dec 15; 104(13):3872-7.